The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•9 March 2026•

1 min read

Biotech Stocks Surge: XENE and RLMD Record Massive Single-Day Gains

Key Facts

1Xenon Pharmaceuticals (XENE) stock surged 49.6% to reach $62.76.

2Relmada Therapeutics (RLMD) stock recorded a 61.1% gain, reaching $7.17.

The biotechnology sector witnessed extraordinary volatility today as Xenon Pharmaceuticals and Relmada Therapeutics saw their share prices skyrocket. Xenon Pharmaceuticals (XENE) shares surged by 49.6%, reaching a closing price of $62.76. Meanwhile, Relmada Therapeutics (RLMD) recorded an even more significant gain of 61.1%, with the stock climbing to $7.17. These massive price movements followed major corporate developments that prompted investors to aggressively re-rate both companies. The magnitude of these gains highlights renewed investor interest in small-cap clinical-stage biotech firms. Such performance is expected to influence broader sentiment within the sector and related exchange-traded funds like IBB and XBI.